Skip to main content

Myocarditis after BNT162b2 mRNA vaccine against COvid-19 in israel

Journal: N Engl J Med
Lead Author: Mevorach, Anis et al.
Original date of publication: 02/02/2021
Link: https://www.academia.edu/106317227/Myocarditis_after_BNT162b2_mRNA_Vaccine_against_Covid_19_in_Israel

Summary Context

Landmark study showed higher rates of myocarditis across the voard for vaccinated people, and comapred to pre-vaccine Covid year 2020

Comments

Similarly high rates of myocarditis and pericarditis for males 16 to 19 years old (150 per 1 million vaccinated) and 20-24 yrs old (108 per 1 million)

Abstract or Results, Key Passages

“The incidence of myocarditis, although low, increased after the receipt of the BNT162b2 vaccine, particularly after the second dose among young male recipients. The clinical presentation of myocarditis after vaccination was usually mild.”


Keywords: adverse eventsCardiac eventscovid vaccinemRNAmyocarditis
Full Author List: Mevorach, Anis, Cedar, Bromberg, . Haas,. Nadir, Olsha-Castell, Arad, Hasin, Levi, Asleh, Amir, Meir, Cohen, Dichtiar, Novick, Hershkovitz, Dagan, I. Leitersdorf, Ben-Ami, Miskin, Saliba, Muhsen, Levi, M.S. Green, Keinan-Boker, Alroy-Preis